Insights from genomic profiling of transcription factors

Nature Reviews Genetics

Volumn 10, Issue 9, 2009, Pages 605-616

  Farnham, Peggy J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREVICAN; ENHANCEOSOME; ESTROGEN RECEPTOR; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HEPATOCYTE NUCLEAR FACTOR 3BETA; INSULIN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYOCYTE ENHANCER FACTOR 2; NEUROTROPHIC TYROSINE KINASE RECEPTOR 1; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN P53; PROTEIN P63; PROTEIN TYROSINE KINASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SERUM RESPONSE FACTOR; STAT1 PROTEIN; TATA BINDING PROTEIN ASSOCIATED FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F4; TRANSCRIPTION FACTOR E2F6; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR TCF4; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

BINDING AFFINITY; BINDING SITE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; DROSOPHILA MELANOGASTER; EPIGENETICS; GENE ASSIGNMENT; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION PROFILING; GENE INTERACTION; GENE LOCATION; GENE MAPPING; GENE SEQUENCE; GENETIC STABILITY; GENOMICS; HUMAN; HUMAN GENOME; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; REGULATORY SEQUENCE; REVIEW;

ANIMALS; BINDING SITES; CHROMOSOME MAPPING; CONSENSUS SEQUENCE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; TRANSCRIPTION FACTORS;

EID: 68949213578     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg2636     Document Type: Review

References (82)

1. Lee, T. I. & Young, R. A. Transcription of eukaryotic protein-coding genes. Annu. Rev. Genet. 34, 77-137 (2000). A detailed review of transcriptional regulation, general factors and accessory proteins that control transcription initation and elongation.
2. Sandelin, A. et al. Mammalian RNA polymerase II core promoters: insights from genome-wide studies. Nature Rev. Genet. 8, 424-436 (2007).
3. ENCODE Project Consortium. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447, 799-816 (2007). This paper demonstrates how genome-wide studies of transcription factor binding, chromatin structure, DNA replication and sequence conservation can synergize.
4. Cooper, S. J., Trinklein, N. D., Anton, E. D., Nguyen, L. & Myers, R. M. Comprehensive analysis of transcriptional promoter structure and function in 1% of the human genome. Genome Res. 16, 1-10 (2006).
5. Kimura, K. et al. Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. Genome Res. 16, 55-65 (2006).
6. Lander, E. S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860-921 (2001).
7. Vaquerizas, J. M., Kummerfeld, S. K., Teichmann, S. A. & Luscombe, N. M. A census of human transcription factors: function, expression and evolution. Nature Rev. Genet. 10, 252-263 (2009). A summary of the expression, conservation and activity of the set of human sequence-specific transcription factors.
8. Venter, J. C. et al. The sequence of the human genome. Science 291, 1304-1351 (2001).
9. Jimenez-Sanchez, G., Childs, B. & Valle, D. Human disease genes. Nature 409, 853-855 (2001).
10. Wederell, E. D. et al. Global analysis of in vivo Foxa2-binding sites in mouse liver using massively parallel sequencing. Nucleic Acids Res. 36, 4549-4564 (2008).
11. Reed, B. D., Charos, A. E., Szekely, A. M., Weissman, S. M. & Snyder, M. Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes. PLOS Genet. 4, e1000133 (2008).
12. Scacheri, P. C. et al. Genome-wide analysis of menin binding provides insights to MEN1 tumorigenesis. PLoS Genet. 2, e51 (2006).
13. Hatzis, P. et al. Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Mol. Cell. Biol. 28, 2732-2744 (2008).
14. O'Geen, H. et al. Genome-wide analysis of KAP1 binding suggests autoregulation of KRAB-ZNFs. PLoS Genet. 3, e89 (2007).
15. Xu, X. et al. A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals iterchangeable roles of E2F family members. Genome Res. 17, 1550-1561 (2007).
16. Robertson, G. et al. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nature Methods 4, 1-7 (2007). An early demonstration that high-throughput sequencing of ChIP samples can be used to identify genome-wide binding sites of site-specific transcription factors.
17. Johnson, D. S., Mortazavi, A., Myers, R. M. & Wold, B. Genome-wide mapping of in vivo protein-DNA interactions. Science 316, 1497-1502 (2007).
18. Rada-Iglesias, A. et al. Whole-genome maps of USF1 and USF2 binding and histone H3 acetylation reveal new aspects of promoter structure and candidate genes for common human disorders. Genome Res. 18, 380-392 (2008).
19. Vogel, M. J., Peric-Hupkes, D. & van Steensel, B. Detection of in vivo protein-DNA interactions using DamID in mammalian cells. Nature Protoc. 2, 1467-1478 (2007).
20. Valouev, A. et al. Genome-wide analysis of transcription factor binding sites based on ChIP-seq data. Nature Methods 5, 829-834 (2008).
21. Johnson, D. S. et al. Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targets. Genome Res. 18, 393-403 (2008).
22. Bieda, M., Xu, X., Singer, M., Green, R. & Farnham, P. J. Unbiased location analysis of E2F1 binding sites suggests a widespread role for E2F1 in the human genome. Genome Res. 16, 595-605 (2006). A demonstration that some factors bind exclusively to proximal promoters and do not have strict motif requirements for their binding sites.
23. Kim, T. H. et al. A high-resolution map of active promoters in the human genome. Nature 436, 876-880 (2005). An early demonstration that high-density oligonucleotide arrays can be used to identify genome-wide binding sites for human transcription factors.
24. Cawley, S. et al. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116, 499-509 (2004).
25. Nix, D. A., Courdy, S. J. & Boucher, K. M. Empirical methods for controlling false positives and estimating confidence in ChIP-seq peaks. BMC Bioinformatics 9, 523 (2008).
26. Zhang, Y. et al. Model-based analysis of ChIP-seq (MACS). Genome Biol. 9, R137 (2008).
27. Fejes, A. P. et al. FindPeaks 3.1: a tool for identifying areas of enrichment from massively parallel short-read sequencing technology. Bioinformatics 24, 1729-1730 (2008).
28. Rozowsky, J. et al. PeakSeq enables systematic scoring of ChIP-seq experiments relative to controls. Nature Biotech. 27, 66-75 (2009).
29. Liu, Y., Michalopoulos, G. K. & Zarnegar, R. Structural and functional characterization of the mouse hepatocyte growth factor gene promoter. J. Biol. Chem. 269, 4152-4160 (1994).
30. Fujishiro, K. et al. Analysis of tissue-specific and PPAR?-dependent induction of FABP gene expression in the mouse liver by an in vivo DNA electroporation method. Mol. Cell. Biochem. 239, 165-172 (2002).
31. Weinmann, A. S., Yan, P. S., Oberley, M. J., Huang, T. H.-M. & Farnham, P. J. Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev. 16, 235-244 (2002).
32. Li, Z. et al. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc. Natl Acad. Sci. USA 100, 8164-8169 (2003).
33. 2/M checkpoints. Genes Dev. 16, 245-256 (2002).
34. Odom, D. T. et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 303, 1378-1381 (2004).
35. Consortium, T. E. P. The ENCODE (ENCyclopedia of DNA Elements) Project. Science 306, 636-640 (2004).
36. Carroll, J. S. et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122, 33-43 (2005).
37. Yang, A. et al. Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. Mol. Cell 24, 593-602 (2006).
38. Chen, X. et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133, 1106-1117 (2008).
39. Mann, R. S. & Carroll, S. B. Molecular mechanisms of selector gene function and evolution. Curr. Opin. Genet. Dev. 12, 592-600 (2002).
40. Moorman, C. et al. Hotspots of transcription factor colocalization in the genome of Drosophila melanogaster. Proc. Natl Acad. Sci. USA 103, 12027-12032 (2006). This demonstrates clustering of transcription factors throughout the D. melanogaster genome.
41. Elnitski, L., Jin, V. X., Farnham, P. J. & Jones, S. J. M. Locating mammalian transcription factor binding sites: a survey of computational and experimental techniques. Genome Res. 16, 1455-1464 (2006).
42. Panne, D. The enhanceosome. Curr. Opin. Struct. Biol. 18, 236-242 (2008).
43. Maniatis, T. et al. Structure and function of the interferon-β enhanceosome. Cold Spring Harb. Symp. Quant. Biol. 63, 609-620 (1998).
44. Dean, A. On a chromosome far, far away: LCRs and gene expression. Trends Genet. 22, 38-45 (2006).
45. Heintzman, N. D. et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459, 108-112 (2009). This identifies specific histone modifications that are associated with cell-type-specific transcriptional regulation.
46. Heintzman, N. D. et al. Distinct predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nature Genet. 39, 311-318 (2007).
47. Wright, W. E. & Funk, W. D. CASTing for multicomponent DNA-binding components. Trends Biochem. Sci. 18, 77-80 (1993).
48. Morgan, X. C., Ni, S., Miranker, D. P. & Iyer, V. R. Predicting combinatorial binding of transcription factors to regulatory elements in the human genome by association rule mining. BMC Bioinformatics 8, 445 (2007).
49. Rabinovich, A., Jin, V. X., Rabinovich, R., Xu, X. & Farnham, P. J. E2F in vivo binding specificity: comparison of consensus versus non-consensus binding sites. Genome Res. 18, 1763-1777 (2008).
50. Gineitis, D. & Treisman, R. Differential usage of signal transduction pathways defines two types of serum response factor target gene. J. Biol. Chem. 276, 24531-24539 (2001).
51. Cooper, S. J., Trinklein, N. D., Nguyen, L. & Myers, R. M. Serum response factor binding sites differ in three human cell types. Genome Res. 17, 136-144 (2009).
52. Jin, V. X., O'Geen, H., Iyengar, S., Green, R. & Farnham, P. J. Identification of an OCT4 and SRY regulatory module using integrated computational and experimental genomics approaches. Genome Res. 17, 807-817 (2007).
53. Li, X.-Y. et al. Transcription factors bind thousands of active and inactive regions in the Drosophila blastoderm. PLoS Biol. 6, e27 (2008).
54. Badis, G. et al. Diversity and complexity in DNA recognition by transcription factors. Science 324, 1720-1723 (2009).
55. Li, H. et al. Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature 442, 91-95 (2006).
56. Pena, P. V. et al. Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2. Nature 442, 100-103 (2006).
57. Shi, X. et al. Proteome-wide analysis in Saccharomyces cerevisiae identifies several PHD fingers as novel direct and selective binding modules of histone H3 methylated at either lysine 4 or lysine 36. J. Biol. Chem. 282, 2450-2455 (2007).
58. Vermeulen, M. et al. Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. Cell 131, 58-69 (2007).
59. Albert, T. et al. The chromatin structure of the dual c-myc promoter P1/P2 is regulated by separate elements. J. Biol. Chem. 276, 20482-20490 (2001).
60. Jin, V. X., Rabinovich, A., Squazzo, S. L., Green, R. & Farnham, P. J. A computational genomics approach to identify cis-regulatory modules from chromatin immunoprecipitation microarray data - a case study using E2F1. Genome Res. 16, 1585-1595 (2006).
61. Krig, S. R. et al. Identification of genes directly regulated by the oncogene ZNF217 using chromatin immunoprecipitation (ChIP)-chip assays. J. Biol. Chem. 282, 9703-9712 (2007).
62. Martone, R. et al. Distribution of NF-κB-binding sites across human chromosome 22. Proc. Natl Acad. Sci. USA 100, 12247-12252 (2003).
63. Krum, S. A. et al. Unique ER? cistromes control cell type-specific gene regulation. Mol. Endocrinol. 22, 2393-2406 (2008).
64. Voss, T. C. & Hager, G. L. Visualizing chromatin dynamics in intact cells. Biochem. Biophys. Acta 1783, 2044-2051 (2008).
65. Osborne, C. S. et al. Active genes dynamically colocalize to shared sites of ongoing transcription. Nature Genet. 36, 1065-1071 (2004).
66. Bartlett, J. et al. Specialized transcription factories. Biochem. Soc. Symp. 73, 67-75 (2006).
67. Dekker, J., Rippe, K., Dekker, M. & Kleckner, N. Capturing chromosome conformation. Science 295, 1306-1311 (2002).
68. Visel, A. et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457, 854-858 (2009). This study demonstrates that using ChIP-seq to identify binding sites for p300 is a highly accurate method for identifying enhancers that can be shown, using follow-up assays in transgenic mice, to function in a tissue-specific manner.
69. Camenisch, T. D., Brilliant, M. H. & Segal, D. J. Critical parameters for genome editing using zinc finger nucleases. Mini Rev. Med. Chem. 8, 669-676 (2008).
70. Bletran, A., Liu, Y., Parikh, S., Temple, B. & Blancafort, P. Interrogating genomes with combinatorial artificial transcription factor libraries: asking zinc finger questions. Assay Drug Dev. Technol. 4, 317-331 (2006).
71. Faruqi, A. F., Egholm, M. & Glazer, P. M. Peptide nucleic acid-targeted mutagenesis of a chromosomal gene in mouse cells. Proc. Natl Acad. Sci. USA 95, 1398-1403 (1998).
72. Burnett, R. et al. DNA sequence-specific polyamides alleviate transcription inhibition associated with long GAA-TCC repeats in Friedreich's ataxia. Proc. Natl Acad. Sci. USA 103, 11497-11502 (2006).
73. Guenther, M. G., Levine, S. S., Boyer, L. A., Jaenisch, R. & Young, R. A. A chromatin landmark and transcription initiation at most promoters in human cells. Cell 130, 77-88 (2007).
74. Muse, G. W. et al. RNA polymerase is poised for activation across the genome. Nature Genet. 39, 1507-1511 (2007).
75. Komashko, V. M. et al. Using ChIP-chip technology to reveal common principles of transcriptional repression in normal and cancer cells. Genome Res. 18, 521-532 (2008).
76. Acevedo, L. G. et al. Genome-scale ChIP-chip analysis using 10,000 human cells. Biotechniques 43, 791-797 (2007).
77. O'Neill, L. P., VerMilyea, M. D. & Turner, B. M. Epigenetic characterization of the early embryo with a chromatin immunoprecipitation protocol applicable to small cell populations. Nature Genet. 38, 835-841 (2006).
78. Dahl, J. A. & Collas, P. Q2ChIP, a quick and quantitative chromatin immunoprecipitation assay, unravels epigenetic dynamics of developmentally regulated genes in human carcinoma cells. Stem Cells 25, 1037-1046 (2007).
79. Attema, J. L. et al. Epigenetic characterization of hematopoietic stem cell differentiation using miniChIP and bisulfite sequencing analysis. Proc. Natl Acad. Sci. USA 104, 12371-12376 (2007).
80. Xu, H., Wei, C.-L., Lin, F. & Sung, W.-K. An HMM approach to genome-wide identification of differential histone modification sites from ChIP-seq data. Bioinformatics 24, 2344-2349 (2008).
81. Jothi, R., Cuddapah, S., Barski, A., Cui, K. & Zhao, K. Genome-wide identification of in vivo protein-DNA binding sites from ChIP-seq data. Nucleic Acids Res. 36, 5221-5231 (2008).
82. Hoffman, B. G. & Jones, S. J. Genome-wide identification of DNA-protein interactions using chromatin immunoprecipitation coupled with flow cell sequencing. J. Endocrinol. 201, 1-13 (2009).